Magnesium citrate
Summary
Magnesium citrate is about 16% elemental magnesium by weight and dissolves well. Human comparisons find it better absorbed than magnesium oxide. A 24-week trial found no effect on arterial stiffness or blood pressure (grade C), and a small 30-day study reported lower bone-turnover markers (grade D).
Key facts
- Magnesium salt of citric acid; usually trimagnesium dicitrate, Mg3(C6H5O7)2[2]
- 16.2% of compound weight (anhydrous): 1,000 mg compound ≈ 162 mg magnesium[2]
- Adults 310–420 mg/day magnesium (all sources); UL 350 mg/day from supplements[1]
- Bisphosphonates, tetracycline and quinolone antibiotics, diuretics, long-term PPIs, high-dose zinc[1][7]
- 2 graded human outcomes on this page
- October 8, 2026
How it works
EstablishedCitrate keeps magnesium soluble: in laboratory tests magnesium citrate dissolved even in water and stayed largely complexed as soluble magnesium citrate, while magnesium oxide was nearly insoluble. Solubility is the established reason it is absorbed better than oxide.[3][1]
What the human research says
Human trials only, one row per outcome. The form column shows what each trial actually tested. Grades follow our evidence-grading policy.
At a glance: strongest evidence per outcome
| Outcome | Grade | Effect | Strongest evidence | Rows |
|---|---|---|---|---|
| Heart | Grade C | No effect | RCT · n = 164 · 2022 | 1 row |
| Bones & joints | Grade D | Improved | Open-label · n = 20 · 2010 | 1 row |
Every graded row
| Outcome | Effect | Grade | Best evidence | PMID |
|---|---|---|---|---|
| Arterial stiffness and blood pressure | No effect | Grade C | RCT · n = 164 · 2022 Adults with overweight or mild obesity, mean age 63 (four arms: citrate, oxide, sulfate, placebo) Form: magnesium citrate (vs oxide, sulfate) · Dose: 450 mg/day magnesium · Duration: 24 weeks Citrate did not change carotid-femoral pulse wave velocity or blood pressure versus placebo. It raised plasma and urinary magnesium, with a larger urinary rise than oxide or sulfate. | 35253448 (opens PubMed)Source [5] |
| Bone-turnover markers | Improved | Grade D | Open-label trial · n = 20 · 2010 Postmenopausal women with osteoporosis; untreated, non-placebo control group Form: magnesium citrate · Dose: 1,830 mg/day magnesium citrate (about 290 mg elemental magnesium per NIH ODS) · Duration: 30 days Parathyroid hormone and urinary deoxypyridinoline fell and osteocalcin rose, suggesting suppressed bone turnover. Markers only; no bone density outcome. | 19488681 (opens PubMed)Source [6] |
Forms
| Form | Elemental % | Absorption (human data) | GI tolerance | Studied for |
|---|---|---|---|---|
| Magnesium glycinate (bisglycinate) | 14.1%[8] | In 12 people with ileal resection, overall absorption of a 100 mg dose did not differ from oxide (23.5% vs 22.8%), but was higher in the 4 with the poorest oxide absorption (23.5% vs 11.8%).[9] | Better tolerated than oxide by all 12 patients in that small crossover trial.[9] | Insomnia severity in adults reporting poor sleep (one RCT). |
| Magnesium citrate | 16.2%[2] | More soluble and more bioavailable than oxide by urinary magnesium in short studies; in a 60-day RCT (n=46) citrate gave the highest serum magnesium of the forms compared.[3][4] | Diarrhea was reported by 18.6% of participants at 600 mg/day in a 12-week migraine trial.[10] | Arterial stiffness and blood pressure (null), bone-turnover markers, migraine attack frequency. |
| Magnesium oxide | 60.3%[17] | Lowest of the forms tested: about 4% fractional absorption in one comparison; poorly soluble in water.[18][3] | One of the forms most often reported to cause diarrhea, per NIH ODS.[1] | Arterial stiffness and blood pressure (null in one 24-week trial). |
- Magnesium oxide603 mg
- Magnesium citrate162 mg
- Magnesium glycinate (bisglycinate)141 mg
Compound weight → elemental magnesium
500 mg magnesium glycinate (bisglycinate) ≈ 71 mg elemental magnesium
Studied doses
Doses studied in human trials ranged from about 290 to 600 mg/day of elemental magnesium as citrate, for 30 days to 24 weeks; 600 mg/day (a 12-week migraine trial) exceeds the 350 mg/day upper limit for supplements.[6][1][5][10]
Intake reference: Adult RDA 310–420 mg/day from all sources (by age and sex). Upper limit for supplemental magnesium: 350 mg/day for adults.[1] The upper limit covers supplements and medicines only, not magnesium in food. NIH ODS fact sheet (updated January 6, 2026).
Interactions
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
Medicines
- Oral bisphosphonatesNIH fact sheetMagnesium-rich supplements or medicines can reduce bisphosphonate absorption; NIH ODS notes separating them by at least 2 hours.[1]
- Tetracycline and quinolone antibioticsNIH fact sheetMagnesium can form insoluble complexes with these antibiotics; NIH ODS notes taking the antibiotic at least 2 hours before or 4–6 hours after magnesium.[1]
- Potassium-sparing diureticsNIH fact sheetReduce urinary magnesium excretion.[1]
Medicines that can lower levels
- Loop and thiazide diureticsNIH fact sheetLong-term use can increase urinary magnesium loss and lead to depletion.[1]
- Proton pump inhibitors (long-term)FDA safety communicationUse typically longer than a year can cause low blood magnesium; in about 25% of cases FDA reviewed, supplements did not correct it and the PPI was stopped.[19][1]
Other supplements
- High-dose zincPK studyLowered magnesium absorption and magnesium balance in a metabolic-ward study of adult men.[7]
Who should be careful
- Kidney problems
- The risk of magnesium toxicity rises with impaired kidney function, because the kidneys remove excess magnesium.[1]
- High intakes and digestive effects
- High doses from supplements or medicines often cause diarrhea, nausea and abdominal cramping. The adult upper limit for supplemental magnesium is 350 mg/day; very large doses from laxatives or antacids (typically over 5,000 mg/day) have caused toxicity.[1]
- Pregnancy and breastfeeding
- The RDA is 350–400 mg/day in pregnancy and 310–360 mg/day during lactation (all sources), and the 350 mg/day upper limit for supplemental magnesium still applies.[1]
- Children
- Upper limits for supplemental magnesium are lower: 65 mg/day at ages 1–3 and 110 mg/day at ages 4–8.[1]
Talk to your pharmacist or clinician before starting a supplement, especially if you take prescription medicines.
Articles about Magnesium citrate
Plain-English answers to common questions, built on the evidence above.
Frequently asked questions
Is magnesium citrate better absorbed than magnesium oxide?
Yes in human comparisons. It was more soluble and raised urinary magnesium more than oxide in a load test, gave the highest serum magnesium in a 60-day trial, and raised 24-hour urinary magnesium more than oxide over 24 weeks.[3][4][5]
How much magnesium is in magnesium citrate?
Anhydrous trimagnesium dicitrate is about 16.2% magnesium by weight, so 1,000 mg of the compound carries about 162 mg. Supplement Facts panels list the elemental amount.[2][1]
Sources
- [1]Magnesium: Fact Sheet for Health Professionals (updated January 6, 2026). NIH Office of Dietary Supplements, 2026. fact-sheet
- [2]Trimagnesium dicitrate (CID 6099959): C12H10Mg3O14, MW 451.12. PubChem, NIH, 2026. database
- [3]Magnesium bioavailability from magnesium citrate and magnesium oxide.. J Am Coll Nutr, 1990. PK-study
- [4]Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study.. Magnes Res, 2003. RCT
- [5]Effects of Magnesium Citrate, Magnesium Oxide, and Magnesium Sulfate Supplementation on Arterial Stiffness: A Randomized, Double-Blind, Placebo-Controlled Intervention Trial.. J Am Heart Assoc, 2022. RCT
- [6]Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women.. Biol Trace Elem Res, 2010. open-label
- [7]Inhibitory effects of zinc on magnesium balance and magnesium absorption in man.. J Am Coll Nutr, 1994. PK-study
- [8]Magnesium glycinate (CID 84645): C4H8MgN2O4, MW 172.42. PubChem, NIH, 2026. database
- [9]Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection.. JPEN J Parenter Enteral Nutr, 1994. crossover-RCT
- [10]Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study.. Cephalalgia, 1996. RCT
- [11]Magnesium L-threonate (CID 45489777): C8H14MgO10, MW 294.50. PubChem, NIH, 2026. database
- [12]Enhancement of learning and memory by elevating brain magnesium.. Neuron, 2010. animal-study
- [13]Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial.. Sleep Med X, 2024. RCT
- [14]The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial.. Front Nutr, 2025. RCT
- [15]Magnesium malate (CID 164748): C4H4MgO5, MW 156.38. PubChem, NIH, 2026. database
- [16]Magnesium taurate (CID 13343447): C4H12MgN2O6S2, MW 272.6. PubChem, NIH, 2026. database
- [17]Magnesium oxide (CID 14792): MgO, MW 40.305. PubChem, NIH, 2026. database
- [18]Bioavailability of US commercial magnesium preparations.. Magnes Res, 2001. PK-study
- [19]FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of proton pump inhibitor drugs (PPIs). U.S. Food and Drug Administration, 2011. safety-communication
- [20]Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials.. Hypertension, 2016. meta-analysis
What changed
- First published.
